Amyris, Inc. (NASDAQ:AMRS) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07
|
Submission of Matters to a Vote of Security Holders. |
On May 23, 2017, Amyris,Inc. (the
Company) held its 2017 Annual Meeting
of Stockholders (the Annual Meeting)
for the following purposes:
|
To elect the four Class I directors nominated by the Companys Board of Directors (the Board) to serve on the Board for a three-year term (Proposal 1). |
||
|
To ratify the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017 (Proposal 2). |
||
|
To approve, on a non-binding advisory basis, the compensation of the Companys named executive officers as disclosed in the Companys definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 27, 2017 (the stockholder say-on-pay vote) (Proposal 3). |
||
|
To hold a non-binding advisory vote regarding the frequency of future stockholder say-on-pay votes (every one, two or three years) (Proposal 4). |
||
|
To re-approve the performance factors set forth in the Companys 2010 Equity Incentive Plan for purposes of Section 162(m) of the Internal Revenue Code (Proposal 5). |
||
|
To approve an amendment to the Companys certificate of incorporation to effect, at the discretion of the Board, a fifteen-to-one reverse stock split of all of the outstanding shares of the Companys common stock, par value $0.0001 per share (Common Stock) (Proposal 6). |
||
|
Subject to the approval of Proposal 6, to approve an amendment to the Companys certificate of incorporation to effect, at the discretion of the Board, a reduction in the total number of authorized shares of Common Stock from 500,000,000 to 250,000,000 (Proposal 7). |
||
|
To act upon such other matters as may properly come before the Annual Meeting or any adjournments or postponements thereof. |
The following Class I directors listed in Proposal 1 were elected
to the Board based on the following votes:
| For | Withhold | Broker Non-Vote | |
| Geoffrey Duyk | 175,083,068 | 2,267,389 | 61,967,738 |
| Carole Piwnica | 176,071,043 | 1,279,414 | 61,967,738 |
| Fernando Reinach | 176,845,139 | 505,318 | 61,967,738 |
| HH Sheikh Abdullah bin Khalifa Al Thani | 120,261,357 | 57,089,100 | 61,967,738 |
Proposal 2 was approved by the following vote:
| For | Against | Abstain | Broker Non-Vote |
| 236,781,530 | 508,400 | 2,028,265 | — |
Proposal 3 was approved by the following vote:
| For | Against | Abstain | Broker Non-Vote |
| 176,016,027 | 1,194,730 | 139,700 | 61,967,738 |
The every three years option in Proposal 4 was approved by the
following vote:
| One Year | Two Years | Three Years | Abstain | Broker Non-Vote |
| 58,524,756 | 10,441,007 | 107,916,444 | 468,250 | 61,967,738 |
Proposal 5 was approved by the following vote:
| For | Against | Abstain | Broker Non-Vote |
| 174,827,146 | 2,143,500 | 379,811 | 61,967,738 |
Proposal 6 was approved by the following vote:
| For | Against | Abstain | Broker Non-Vote |
| 219,285,869 | 15,800,440 | 417,135 | — |
Proposal 7 was approved by the following vote:
| For | Against | Abstain | Broker Non-Vote |
| 175,848,276 | 1,279,895 | 222,286 | 61,967,738 |
No further business was brought before the Annual Meeting.
About Amyris, Inc. (NASDAQ:AMRS)
Amyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product. Amyris, Inc. (NASDAQ:AMRS) Recent Trading Information
Amyris, Inc. (NASDAQ:AMRS) closed its last trading session down -0.001 at 0.271 with 3,166,447 shares trading hands.
